共 39 条
[3]
The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (gleevec): Implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients
[J].
CANCER RESEARCH,
2005, 65 (07)
:2577-2582
[6]
Choo EF, 2000, DRUG METAB DISPOS, V28, P655
[8]
Cohen MH, 2005, CLIN CANCER RES, V11, P12
[10]
Dagher R, 2002, CLIN CANCER RES, V8, P3034